Artículos Científicos

Editor: NOEL GONZÁLEZ GOTERA Número 112 Diseño: Lic. Roberto Chávez y Liuder Machado. Semana 301113 – 061213 Foto: Lic. Belkis Romeu e Instituto Finlay La Habana, Cuba.

ARTÍCULOS CIENTÍFICOS

Publicaciones incluidas en PubMED durante el período comprendido entre el 29 de noviembre y el 6 de diciembre de 2013. Con “vaccin*” en título: 115 artículos recuperados.

Vacunas Meningococo (Neisseria meningitidis)

35. [A new preventio strategy against meningococcal disease: the menigococcus B vaccine].

Gil De Miguel A.

An R Acad Nac Med (Madr). 2012;129(1):267-74; discussion 275-7. Spanish.

PMID: 24294728 [PubMed - in process]

Related citations

Select item 24294248

106. Modelled evaluation of multi-component meningococcal vaccine (Bexsero®) for the prevention of invasive meningococcal disease in infants and adolescents in the UK.

Huels J, Clements KM, McGarry LJ, Hill GJ, Wassil J, Kessabi S.

Epidemiol Infect. 2013 Nov 28:1-13. [Epub ahead of print]

PMID: 24284038 [PubMed - as supplied by publisher]

Related citations

Select item 24283990

Vacunas BCG – ONCO BCG (Mycobacterium bovis)

1. Paratuberculosis vaccination causes only limited cross-reactivity in the skin test for diagnosis of bovine tuberculosis.

Garrido JM, Vazquez P, Molina E, Plazaola JM, Sevilla IA, Geijo MV, Alonso-Hearn M, Juste RA.

PLoS One. 2013 Nov 26;8(11):e80985. doi: 10.1371/journal.pone.0080985.

PMID: 24303029 [PubMed - in process]

Related citations

Select item 24302925

36. Bovine response to lipoarabinomannan vaccination and challenge with Mycobacterium paratuberculosis.

Jolly A, Morsella C, Bass L, Fiorentino MA, Paolicchi FA, Mundo SL.

Braz J Microbiol. 2013 Oct 30;44(2):511-4. doi: 10.1590/S1517-83822013000200029.

PMID: 24294248 [PubMed - in process] Free Article

Related citations

Select item 24293813

72. BCG and BCG/DNAhsp65 Vaccinations Promote Protective Effects without Deleterious Consequences for Experimental Autoimmune Encephalomyelitis.

Zorzella-Pezavento SF, Guerino CP, Chiuso-Minicucci F, França TG, Ishikawa LL, Masson AP, Silva CL, Sartori A.

Clin Dev Immunol. 2013;2013:721383. doi: 10.1155/2013/721383. Epub 2013 Oct 29.

PMID: 24288555 [PubMed - in process] Free PMC Article

Related citations

Select item 24288554

Vacunas Neumococo (Streptococcus pneumoniae)

3. Conjugate Pneumococcal Vaccines: Need and Choice in India.

Malik A, Taneja D.

Indian J Community Med. 2013 Oct;38(4):189-191. No abstract available.

PMID: 24302817 [PubMed - as supplied by publisher]

Related citations

Select item 24302799

10. Decreased immune response to pneumococcal conjugate vaccine after 23-valent pneumococcal polysaccharide vaccine in children.

Sigurdardottir ST, Center KJ, Davidsdottir K, Arason VA, Hjalmarsson B, Elisdottir R, Ingolfsdottir G, Northington R, Scott DA, Jonsdottir I.

Vaccine. 2013 Nov 30. doi:pii: S0264-410X(13)01546-6. 10.1016/j.vaccine.2013.11.029. [Epub ahead of print]

PMID: 24300594 [PubMed - as supplied by publisher]

Related citations

Select item 24300593

15. Invasive pneumococcal disease, co-morbidities and polysaccharide vaccine use in 5-15 year- old children in England and Wales.

Ladhani SN, Andrews NJ, Waight P, Borrow R, Slack MP, Miller E.

Clin Infect Dis. 2013 Dec 2. [Epub ahead of print]

PMID: 24300040 [PubMed - as supplied by publisher]

Related citations

Select item 24299731

74. Cost Effectiveness of the New Pneumococcal Vaccines: A Systematic Review of European Studies. van de Vooren K, Duranti S, Curto A, Garattini L.

Pharmacoeconomics. 2013 Nov 28. [Epub ahead of print]

PMID: 24288207 [PubMed - as supplied by publisher]

Related citations

Select item 24288046

Vacunas Fiebre tifoidea (Salmonella typhi)

63. Immunogenicity and safety of the Vi-CRM₁₉₇ conjugate vaccine against typhoid fever in adults, children, and infants in south and southeast Asia: results from two randomised, observer-blind, age de-escalation, phase 2 trials.

Bhutta ZA, Capeding MR, Bavdekar A, Marchetti E, Ariff S, Soofi SB, Anemona A, Habib MA, Alberto E, Juvekar S, Khan RM, Marhaba R, Ali N, Malubay N, Kawade A, Saul A, Martin LB, Podda A.

Lancet Infect Dis. 2013 Nov 27. doi:pii: S1473-3099(13)70241-X. 10.1016/S1473- 3099(13)70241-X. [Epub ahead of print]

PMID: 24290843 [PubMed - as supplied by publisher]

Related citations

Select item 24290842

64. A conjugate vaccine against typhoid fever.

Park SE, Marks F.

Lancet Infect Dis. 2013 Nov 27. doi:pii: S1473-3099(13)70292-5. 10.1016/S1473- 3099(13)70292-5. [Epub ahead of print] No abstract available.

PMID: 24290842 [PubMed - as supplied by publisher]

Related citations

Select item 24290278

Vacuna Tosferina (Bordetella pertussis)

45. Time since last vaccine dose in PCR-positive and PCR-negative children with suspected pertussis to monitor pertussis vaccine effectiveness.

Riffelmann M, Mohr J, Hellenbrand W, Wirsing von Koenig CH.

Eur J Clin Microbiol Infect Dis. 2013 Dec 1. [Epub ahead of print]

PMID: 24292098 [PubMed - as supplied by publisher]

Related citations

Select item 24292083

Vacuna Tuberculosis (Mycobacterium tuberculosis)

30. Therapeutic vaccination against relevant high virulence clinical isolates of Mycobacterium tuberculosis.

Shanley CA, Ireton GC, Baldwin SL, Coler RN, Reed SG, Basaraba RJ, Orme IM.

Tuberculosis (Edinb). 2013 Sep 7. doi:pii: S1472-9792(13)00159-5. 10.1016/j.tube.2013.08.010. [Epub ahead of print]

PMID: 24295653 [PubMed - as supplied by publisher]

Related citations

Select item 24294986

98. TB vaccine failure was predictable.

Beverley P.

Nature. 2013 Nov 28;503(7477):469. doi: 10.1038/503469e. No abstract available.

PMID: 24284721 [PubMed - in process]

Related citations

Select item 24284413

112. Critical Research Concepts in TB Vaccine Development.

Delogu G, Manganelli R, Brennan MJ.

Clin Microbiol Infect. 2013 Nov 27. doi: 10.1111/1469-0691.12460. [Epub ahead of print]

PMID: 24283256 [PubMed - as supplied by publisher]

Related citations

Select item 24283223

Adyuvantes

4. Alginate Nanoparticles as a Promising Adjuvant and Vaccine Delivery System.

Sarei F, Dounighi NM, Zolfagharian H, Khaki P, Bidhendi SM.

Indian J Pharm Sci. 2013 Jul;75(4):442-449.

PMID: 24302799 [PubMed - as supplied by publisher]

Related citations

Select item 24302755

9. Recent progress in adjuvant discovery for peptide-based subunit vaccines.

Azmi F, Ahmad Fuaad AA, Skwarczynski M, Toth I.

Hum Vaccin Immunother. 2013 Dec 3;10(3). [Epub ahead of print] Review.

PMID: 24300669 [PubMed - as supplied by publisher]

Related citations

Select item 24300594

Vacunas, otras

1. Paratuberculosis vaccination causes only limited cross-reactivity in the skin test for diagnosis of bovine tuberculosis.

Garrido JM, Vazquez P, Molina E, Plazaola JM, Sevilla IA, Geijo MV, Alonso-Hearn M, Juste RA. 5

PLoS One. 2013 Nov 26;8(11):e80985. doi: 10.1371/journal.pone.0080985.

PMID: 24303029 [PubMed - in process]

Related citations

Select item 24302925 2.

Dendritic Cell Vaccination, Immune Regulation, and Clinical Outcomes in Ovarian Cancer.

Goyne HE, Cannon MJ.

Front Immunol. 2013 Nov 18;4:382. Review.

PMID: 24302925 [PubMed - as supplied by publisher]

Related citations

Select item 24302817 3.

Conjugate Pneumococcal Vaccines: Need and Choice in India.

Malik A, Taneja D.

Indian J Community Med. 2013 Oct;38(4):189-191. No abstract available.

PMID: 24302817 [PubMed - as supplied by publisher]

Related citations

Select item 24302799 4.

Alginate Nanoparticles as a Promising Adjuvant and Vaccine Delivery System.

Sarei F, Dounighi NM, Zolfagharian H, Khaki P, Bidhendi SM.

Indian J Pharm Sci. 2013 Jul;75(4):442-449.

PMID: 24302799 [PubMed - as supplied by publisher]

Related citations

Select item 24302755 5.

The effect of chronic cytomegalovirus infection on pneumococcal vaccine responses.

O'Connor D, Trück J, Lazarus R, Clutterbuck EA, Voysey M, Jeffery K, Pollard AJ.

J Infect Dis. 2013 Dec 2. [Epub ahead of print]

PMID: 24302755 [PubMed - as supplied by publisher]

Related citations

Select item 24301732 6.

[Impact assessment of the rotavirus vaccine in Colombia using rapid evaluation methods].

Cotes K, Alvis-Guzmán N, Rico A, Porras A, Cediel N, Chocontá Piraquive LA, De la Hoz F.

Rev Panam Salud Publica. 2013 Oct;34(4):220-6. Spanish.

PMID: 24301732 [PubMed - in process]

Related citations

Select item 24301228 7.

A randomized, controlled, blinded study of the safety, immunogenicity and batch consistency of Aleph inactivated split influenza vaccine made in China in Chinese people.

Shi N, Yang L, Bai Y, Ai X, Wang Z, Han H, Lu Q, Luo F, Li S, Zhang Z, Li L.

Hum Vaccin Immunother. 2013 Dec 3;10(3). [Epub ahead of print]

PMID: 24301228 [PubMed - as supplied by publisher]

Related citations

Select item 24300889 8.

Common Antigens Prediction in Bacterial Bioweapons: A Perspective for Vaccine Design.

Jaiswal V, Chauhan RS, Rout C.

Infect Genet Evol. 2013 Nov 30. doi:pii: S1567-1348(13)00423-1. 10.1016/j.meegid.2013.11.011. [Epub ahead of print]

PMID: 24300889 [PubMed - as supplied by publisher]

Related citations

Select item 24300669 9.

Recent progress in adjuvant discovery for peptide-based subunit vaccines.

Azmi F, Ahmad Fuaad AA, Skwarczynski M, Toth I.

Hum Vaccin Immunother. 2013 Dec 3;10(3). [Epub ahead of print] Review.

PMID: 24300669 [PubMed - as supplied by publisher]

Related citations

Select item 24300594 10.

Decreased immune response to pneumococcal conjugate vaccine after 23-valent pneumococcal polysaccharide vaccine in children.

Sigurdardottir ST, Center KJ, Davidsdottir K, Arason VA, Hjalmarsson B, Elisdottir R, Ingolfsdottir G, Northington R, Scott DA, Jonsdottir I.

Vaccine. 2013 Nov 30. doi:pii: S0264-410X(13)01546-6. 10.1016/j.vaccine.2013.11.029. [Epub ahead of print]

PMID: 24300594 [PubMed - as supplied by publisher]

Related citations

Select item 24300593 11.

Twenty-five years of the WHO vaccines prequalification programme (1987-2012): Lessons learned and future perspectives.

Dellepiane N, Wood D.

Vaccine. 2013 Nov 30. doi:pii: S0264-410X(13)01628-9. 10.1016/j.vaccine.2013.11.066. [Epub ahead of print]

PMID: 24300593 [PubMed - as supplied by publisher]

Related citations

Select item 24300591 12.

Oral polio vaccine response in breast fed infants with malnutrition and diarrhea.

Haque R, Snider C, Liu Y, Ma JZ, Liu L, Nayak U, Mychaleckyj JC, Korpe P, Mondal D, Kabir M, Alam M, Pallansch M, Oberste MS, Weldon W, Kirkpatrick BD, Petri WA.

Vaccine. 2013 Nov 30. doi:pii: S0264-410X(13)01590-9. 10.1016/j.vaccine.2013.11.056. [Epub ahead of print]

PMID: 24300591 [PubMed - as supplied by publisher]

Related citations

Select item 24300513 13.

Adjuvant Effect of Cationic Liposomes for Subunit Influenza Vaccine: Influence of Antigen Loading Method, Cholesterol and Immune Modulators.

Barnier-Quer C, Elsharkawy A, Romeijn S, Kros A, Jiskoot W.

Pharmaceutics. 2013 Jul 25;5(3):392-410.

PMID: 24300513 [PubMed - as supplied by publisher]

Related citations

Select item 24300403 14.

Vaccine Safety Surveillance Systems: Critical Elements and Lessons Learned in the Development of the US Vaccine Safety Datalink's Rapid Cycle Analysis Capabilities.

Davis RL.

Pharmaceutics. 2013 Mar 12;5(1):168-178.

PMID: 24300403 [PubMed - as supplied by publisher]

Related citations

Select item 24300040 15.

Invasive pneumococcal disease, co-morbidities and polysaccharide vaccine use in 5-15 year-old children in England and Wales.

Ladhani SN, Andrews NJ, Waight P, Borrow R, Slack MP, Miller E.

Clin Infect Dis. 2013 Dec 2. [Epub ahead of print]

PMID: 24300040 [PubMed - as supplied by publisher]

Related citations

Select item 24299731 16.

Vaccine quality and safety: Scrutinizing the reported 3-fold increase in adverse effects following immunization (Aefi) in India.

Patil RR.

Hum Vaccin Immunother. 2013 Dec 3;10(3). [Epub ahead of print]

PMID: 24299731 [PubMed - as supplied by publisher]

Related citations

Select item 24298886 17.

Promotional communications for influenza vaccination: a systematic review.

Macdonald L, Cairns G, Angus K, de Andrade M.

J Health Commun. 2013 Dec;18(12):1523-49. doi: 10.1080/10810730.2013.840697.

PMID: 24298886 [PubMed - in process]

Related citations

Select item 24298125 18.

A cross-sectional audit of the uptake of the seasonal influenza vaccination by medical staff at a London hospital.

Isaacs A, Chryssanthakis A, Abraham S.

Clin Med. 2013 Dec;13(6):633. doi: 10.7861/clinmedicine.13-6-633. No abstract available.

PMID: 24298125 [PubMed - in process]

Related citations

Select item 24298020 19.

Vaccinia-related kinase 2 mediates accumulation of polyglutamine aggregates via negative regulation of the chaperonin TRiC.

Kim S, Park DY, Lee D, Kim W, Jeong YH, Lee J, Chung SK, Ha H, Choi BH, Kim KT.

Mol Cell Biol. 2013 Dec 2. [Epub ahead of print]

PMID: 24298020 [PubMed - as supplied by publisher]

Related citations

Select item 24297878 20.

Pentameric complex of viral glycoprotein H is the primary target for potent neutralization by a human cytomegalovirus vaccine.

Freed DC, Tang Q, Tang A, Li F, He X, Huang Z, Meng W, Xia L, Finnefrock AC, Durr E, Espeseth AS, Casimiro DR, Zhang N, Shiver JW, Wang D, An Z, Fu TM.

Proc Natl Acad Sci U S A. 2013 Dec 2. [Epub ahead of print]

PMID: 24297878 [PubMed - as supplied by publisher] Free Article

Related citations

Select item 24297842 21.

Suppression of boar taint in cryptorchid pigs using a vaccine against the gonadotropin- releasing hormone.

Gutzwiller, Ampuero Kragten.

Schweiz Arch Tierheilkd. 2013 Dec;155(12):677-80. doi: 10.1024/0036- 7281/a000533.

PMID: 24297842 [PubMed - in process]

Related citations

Select item 24297427 22.

Vaccine production: upstream processing with adherent or suspension cell lines.

Genzel Y, Rödig J, Rapp E, Reichl U.

Methods Mol Biol. 2014;1104:371-93. doi: 10.1007/978-1-62703-733-4_23.

PMID: 24297427 [PubMed - in process]

Related citations

Select item 24297190 23.

Examination of links between herpes zoster incidence and childhood varicella vaccination.

Hales CM, Harpaz R, Joesoef MR, Bialek SR.

Ann Intern Med. 2013 Dec 3;159(11):739-45. doi: 10.7326/0003-4819-159-11- 201312030-00006.

PMID: 24297190 [PubMed - in process]

Related citations

Select item 24296931 24.

Human papillomavirus vaccine in patients with systemic lupus erythematosus.

Pellegrino P, Carnovale C, Perrone V, Salvati D, Gentili M, Antoniazzi S, Clementi E, Radice S.

Epidemiology. 2014 Jan;25(1):155-6. doi: 10.1097/EDE.0000000000000033. No abstract available.

PMID: 24296931 [PubMed - in process]

Related citations

Select item 24295808 25.

Nanoparticle vaccines.

Zhao L, Seth A, Wibowo N, Zhao CX, Mitter N, Yu C, Middelberg AP.

Vaccine. 2013 Nov 29. doi:pii: S0264-410X(13)01631-9. 10.1016/j.vaccine.2013.11.069. [Epub ahead of print]

PMID: 24295808 [PubMed - as supplied by publisher]

Related citations

Select item 24295807 26.

Antibody response to human papillomavirus vaccine in subjects with inherited bone marrow failure syndromes.

Alter BP, Giri N, Pan Y, Savage SA, Pinto LA.

Vaccine. 2013 Nov 29. doi:pii: S0264-410X(13)01582-X. 10.1016/j.vaccine.2013.11.048. [Epub ahead of print]

PMID: 24295807 [PubMed - as supplied by publisher]

Related citations

Select item 24295806 27.

Economic evaluations of implemented vaccination programmes: key methodological challenges in retrospective analyses.

Newall AT, Reyes JF, Wood JG, McIntyre P, Menzies R, Beutels P.

Vaccine. 2013 Nov 29. doi:pii: S0264-410X(13)01629-0. 10.1016/j.vaccine.2013.11.067. [Epub ahead of print]

PMID: 24295806 [PubMed - as supplied by publisher]

Related citations

Select item 24295804 28.

Literature review of HPV vaccine delivery strategies: Considerations for school- and non-school based immunization program.

Paul P, Fabio A.

Vaccine. 2013 Nov 29. doi:pii: S0264-410X(13)01632-0. 10.1016/j.vaccine.2013.11.070. [Epub ahead of print]

PMID: 24295804 [PubMed - as supplied by publisher]

Related citations

Select item 24295803 29.

Novel vaccination approaches against equine alphavirus encephalitides.

Carossino M, Thiry E, de la Grandière A, Barrandeguy ME.

Vaccine. 2013 Nov 29. doi:pii: S0264-410X(13)01633-2. 10.1016/j.vaccine.2013.11.071. [Epub ahead of print]

PMID: 24295803 [PubMed - as supplied by publisher]

Related citations

Select item 24295653 30.

Therapeutic vaccination against relevant high virulence clinical isolates of Mycobacterium tuberculosis.

Shanley CA, Ireton GC, Baldwin SL, Coler RN, Reed SG, Basaraba RJ, Orme IM.

Tuberculosis (Edinb). 2013 Sep 7. doi:pii: S1472-9792(13)00159-5. 10.1016/j.tube.2013.08.010. [Epub ahead of print]

PMID: 24295653 [PubMed - as supplied by publisher]

Related citations

Select item 24294986 31.

Listening to the rumours: What the northern Nigeria polio vaccine boycott can tell us ten years on.

Ghinai I, Willott C, Dadari I, Larson HJ.

Glob Public Health. 2013 Dec 3. [Epub ahead of print]

PMID: 24294986 [PubMed - as supplied by publisher]

Related citations

Select item 24294952 32.

Mice immunogenicity after vaccination by DNA vaccines containing individual genes of a new type of reovirus.

Bai B, Shen H, Hu Y, Hou J, Li R, Liu Z, Luo S, Mao P.

Acta Virol. 2013;57(4):397-404.

PMID: 24294952 [PubMed - in process]

Related citations

Select item 24294834 33.

Combined immunodeficiency presenting with vaccine-associated paralytic poliomyelitis: a case report and narrative review of literature.

Shaghaghi M, Parvaneh N, Ostad-Rahimi P, Fathi SM, Shahmahmoodi S, Abolhassani H, Aghamohammadi A.

Immunol Invest. 2013 Dec 2. [Epub ahead of print]

PMID: 24294834 [PubMed - as supplied by publisher]

Related citations

Select item 24294730 34.

[Treatment and prevention of tobacco addiction. Antinicotinic vaccine].

Fernández PL.

An R Acad Nac Med (Madr). 2012;129(1):295-304; discussion 304-6. Spanish.

PMID: 24294730 [PubMed - in process]

Related citations

Select item 24294728 35.

[A new preventio strategy against meningococcal disease: the menigococcus B vaccine].

Gil De Miguel A.

An R Acad Nac Med (Madr). 2012;129(1):267-74; discussion 275-7. Spanish.

PMID: 24294728 [PubMed - in process]

Related citations

Select item 24294248 36.

Bovine response to lipoarabinomannan vaccination and challenge with Mycobacterium paratuberculosis.

Jolly A, Morsella C, Bass L, Fiorentino MA, Paolicchi FA, Mundo SL.

Braz J Microbiol. 2013 Oct 30;44(2):511-4. doi: 10.1590/S1517-83822013000200029.

PMID: 24294248 [PubMed - in process] Free Article

Related citations

Select item 24293813 37.

Higher Immunological Protection of Pandemic 2009 H1N1 Influenza Live Virus Infection than Split Vaccine Against the Homologous Virus for Long Term Immunization in Ferret.

Zhan L, Deng W, Bao L, Lv Q, Ma C, Li F, Xu L, Qin C.

Indian J Virol. 2012 Dec;23(3):270-277. Epub 2012 Sep 28.

PMID: 24293813 [PubMed - as supplied by publisher]

Related citations

Select item 24293811 38.

Recent Advances in Development of DNA Vaccines Against Hepatitis C virus.

Ullah S, Shah MA, Riaz N.

Indian J Virol. 2012 Dec;23(3):253-260. Epub 2012 Mar 20. Review.

PMID: 24293811 [PubMed - as supplied by publisher]

Related citations

Select item 24293713 39.

Altered Transcriptome of the B. melitensis Vaccine Candidate 16MΔvjbR, Implications for Development of Genetically Marked Live Vaccine.

Ke Y, Wang Y, Yuan X, Zhong Z, Qu Q, Zhou D, Zeng X, Xu J, Wang Z, Du X, Wang T, Yang R, Zhen Q, Yu Y, Huang L, Chen Z.

Indian J Microbiol. 2012 Dec;52(4):575-580. Epub 2012 Aug 2.

PMID: 24293713 [PubMed - as supplied by publisher]

Related citations

Select item 24293627 40.

CD8+ T Cell-Independent Tumor Regression Induced by Fc-OX40L and Therapeutic Vaccination in a Mouse Model of Glioma.

Murphy KA, Erickson JR, Johnson CS, Seiler CE, Bedi J, Hu P, Pluhar GE, Epstein AL, Ohlfest JR.

J Immunol. 2013 Nov 29. [Epub ahead of print]

PMID: 24293627 [PubMed - as supplied by publisher]

Related citations

Select item 24293446 41.

Pre-exposure vaccination against rabies.

Dawson J.

Vet Rec. 2013 Nov 30;173(21):532. doi: 10.1136/vr.f7083. No abstract available.

PMID: 24293446 [PubMed - in process]

Related citations

Select item 24292709 42.

Vaccine-induced monoclonal antibodies targeting circumsporozoite protein prevent Plasmodium falciparum infection.

Foquet L, Hermsen CC, van Gemert GJ, Van Braeckel E, Weening KE, Sauerwein R, Meuleman P, Leroux-Roels G.

J Clin Invest. 2013 Dec 2. doi:pii: 70349. 10.1172/JCI70349. [Epub ahead of print]

PMID: 24292709 [PubMed - as supplied by publisher]

Related citations

Select item 24292514 43.

Nanoparticle-detained toxins for safe and effective vaccination.

Hu CM, Fang RH, Luk BT, Zhang L.

Nat Nanotechnol. 2013 Dec;8(12):933-8. doi: 10.1038/nnano.2013.254. Epub 2013 Dec 1.

PMID: 24292514 [PubMed - in process]

Related citations

Select item 24292185 44.

From basic principles to clinical applications on transcutaneous vaccine.

Okada N.

Yakugaku Zasshi. 2013;133(12):1363-72.

PMID: 24292185 [PubMed - in process] Free Article

Related citations

Select item 24292098 45.

Time since last vaccine dose in PCR-positive and PCR-negative children with suspected pertussis to monitor pertussis vaccine effectiveness.

Riffelmann M, Mohr J, Hellenbrand W, Wirsing von Koenig CH.

Eur J Clin Microbiol Infect Dis. 2013 Dec 1. [Epub ahead of print]

PMID: 24292098 [PubMed - as supplied by publisher]

Related citations

Select item 24292083 46.

Varicella-zoster virus vaccine, successes and difficulties.

Sarkadi J.

Acta Microbiol Immunol Hung. 2013 Dec;60(4):379-96. doi: 10.1556/AMicr.60.2013.4.1.

PMID: 24292083 [PubMed - in process]

Related citations

Select item 24292020 47.

A recombinant influenza virus vaccine expressing the F protein of respiratory syncytial virus.

Fonseca W, Ozawa M, Hatta M, Orozco E, Martínez MB, Kawaoka Y.

Arch Virol. 2013 Dec 1. [Epub ahead of print]

PMID: 24292020 [PubMed - as supplied by publisher]

Related citations

Select item 24291739 48.

Characterization and evaluation of the immune responses elicited by a novel human papillomavirus (HPV) therapeutic vaccine: HPV 16E7-HBcAg-Hsp65 fusion protein.

Zhou CM, Zhang GX, Ma XX.

J Virol Methods. 2013 Nov 27. doi:pii: S0166-0934(13)00447-3. 10.1016/j.jviromet.2013.10.033. [Epub ahead of print]

PMID: 24291739 [PubMed - as supplied by publisher]

Related citations

Select item 24291713 49.

A vaccine formulated with a combination of TLR-2 and TLR-9 adjuvants and the recombinant major outer membrane protein elicits a robust immune response and significant protection against a C. muridarum challenge.

Cheng C, Pal S, Tifrea D, Jia Z, de la Maza LM.

Microbes Infect. 2013 Nov 26. doi:pii: S1286-4579(13)00251-7. 10.1016/j.micinf.2013.11.009. [Epub ahead of print]

PMID: 24291713 [PubMed - as supplied by publisher]

Related citations

Select item 24291540 50.

A dual vaccine candidate against norovirus and hepatitis E virus.

Wang L, Cao D, Wei C, Meng XJ, Jiang X, Tan M.

Vaccine. 2013 Nov 27. doi:pii: S0264-410X(13)01598-3. 10.1016/j.vaccine.2013.11.064. [Epub ahead of print]

PMID: 24291540 [PubMed - as supplied by publisher]

Related citations

Select item 24291539 51.

Vaccination benefits and cost-sharing policy for non-institutionalized adult Medicaid enrollees.

Stewart AM, Lindley MC, Chang KH, Cox MA.

Vaccine. 2013 Nov 27. doi:pii: S0264-410X(13)01584-3. 10.1016/j.vaccine.2013.11.050. [Epub ahead of print]

PMID: 24291539 [PubMed - as supplied by publisher]

Related citations

Select item 24291538 52.

Examining the views of key stakeholders regarding the provision of occupational influenza vaccination for healthcare workers in Australia.

Lim YC, Seale H.

Vaccine. 2013 Nov 27. doi:pii: S0264-410X(13)01597-1. 10.1016/j.vaccine.2013.11.063. [Epub ahead of print]

PMID: 24291538 [PubMed - as supplied by publisher]

Related citations

Select item 24291201 53.

Influenza vaccination and risk of hospitalization among adults with laboratory confirmed influenza illness.

McLean HQ, Meece JK, Belongia EA.

Vaccine. 2013 Nov 26. doi:pii: S0264-410X(13)01594-6. 10.1016/j.vaccine.2013.11.060. [Epub ahead of print]

PMID: 24291201 [PubMed - as supplied by publisher]

Related citations

Select item 24291200 54.

Estimation of the potential overall impact of human papillomavirus vaccination on cervical cancer cases and deaths.

Van Kriekinge G, Castellsagué X, Cibula D, Demarteau N.

Vaccine. 2013 Nov 26. doi:pii: S0264-410X(13)01583-1. 10.1016/j.vaccine.2013.11.049. [Epub ahead of print]

PMID: 24291200 [PubMed - as supplied by publisher]

Related citations

Select item 24291199 55.

Memory CD8⁺ T cells elicited by HIV-1 lipopeptide vaccines display similar phenotypic profiles but differences in term of magnitude and multifunctionality compared with FLU- or EBV-specific memory T cells in humans.

Figueiredo S, Charmeteau B, Surenaud M, Salmon D, Launay O, Guillet JG, Hosmalin A, Gahery H.

Vaccine. 2013 Nov 26. doi:pii: S0264-410X(13)01586-7. 10.1016/j.vaccine.2013.11.052. [Epub ahead of print]

PMID: 24291199 [PubMed - as supplied by publisher]

Related citations

Select item 24291198 56.

Disease-related adverse events following non-live vaccines: Investigation of a newly described reporting bias through the analysis of the WHO Global ICSR Database, VigiBase.

Roberto G, Zanoni G.

Vaccine. 2013 Nov 26. doi:pii: S0264-410X(13)01585-5. 10.1016/j.vaccine.2013.11.051. [Epub ahead of print]

PMID: 24291198 [PubMed - as supplied by publisher]

Related citations

Select item 24291197 57.

DNA vaccination against a fish rhabdovirus promotes an early chemokine-related recruitment of B cells to the muscle.

Castro R, Martínez-Alonso S, Fischer U, Haro NA, Soto-Lampe V, Wang T, Secombes CJ, Lorenzen N, Lorenzen E, Tafalla C.

Vaccine. 2013 Nov 26. doi:pii: S0264-410X(13)01596-X. 10.1016/j.vaccine.2013.11.062. [Epub ahead of print]

PMID: 24291197 [PubMed - as supplied by publisher]

Related citations

Select item 24291193 58.

Impact of malaria and helminth infections on immunogenicity of the human papillomavirus-16/18 AS04-adjuvanted vaccine in Tanzania.

Brown J, Baisley K, Kavishe B, Changalucha J, Andreasen A, Mayaud P, Gumodoka B, Kapiga S, Hayes R, Watson-Jones D.

Vaccine. 2013 Nov 26. doi:pii: S0264-410X(13)01595-8. 10.1016/j.vaccine.2013.11.061. [Epub ahead of print]

PMID: 24291193 [PubMed - as supplied by publisher]

Related citations

Select item 24291168 59.

Efficacy and safety of a patch vaccine containing heat-labile toxin from Escherichia coli against travellers' diarrhoea: a phase 3, randomised, double-blind, placebo-controlled field trial in travellers from Europe to Mexico and Guatemala.

Behrens RH, Cramer JP, Jelinek T, Shaw H, von Sonnenburg F, Wilbraham D, Weinke T, Bell DJ, Asturias E, Pauwells HL, Maxwell R, Paredes-Paredes M, Glenn GM, Dewasthaly S, Stablein DM, Jiang ZD, Dupont HL.

Lancet Infect Dis. 2013 Nov 28. doi:pii: S1473-3099(13)70297-4. 10.1016/S1473- 3099(13)70297-4. [Epub ahead of print]

PMID: 24291168 [PubMed - as supplied by publisher]

Related citations

Select item 24291167 60.

Moving beyond a heat-labile enterotoxin-based vaccine against enterotoxigenic Escherichia coli.

Riddle MS, Savarino SJ.

Lancet Infect Dis. 2013 Nov 28. doi:pii: S1473-3099(13)70355-4. 10.1016/S1473- 3099(13)70355-4. [Epub ahead of print] No abstract available.

PMID: 24291167 [PubMed - as supplied by publisher]

Related citations

Select item 24291126 61.

Development of a luciferase based viral inhibition assay to evaluate vaccine induced CD8 T-cell responses.

Naarding MA, Fernandez-Fernandez N, Kappes JC, Hayes P, Ahmed T, Icyuz M, Edmonds TG, Bergin P, Anzala O, Hanke T, Clark L, Cox JH, Cormier E, Ochsenbauer C, Gilmour J.

J Immunol Methods. 2013 Nov 28. doi:pii: S0022-1759(13)00358-X. 10.1016/j.jim.2013.11.021. [Epub ahead of print]

PMID: 24291126 [PubMed - as supplied by publisher]

Related citations

Select item 24291062 62.

The burden of influenza in England by age and clinical risk group: a statistical analysis to inform vaccine policy.

Cromer D, Hoek AJ, Jit M, Edmunds WJ, Fleming D, Miller E.

J Infect. 2013 Nov 28. doi:pii: S0163-4453(13)00373-3. 10.1016/j.jinf.2013.11.013. [Epub ahead of print]

PMID: 24291062 [PubMed - as supplied by publisher]

Related citations

Select item 24290843 63.

Immunogenicity and safety of the Vi-CRM₁₉₇ conjugate vaccine against typhoid fever in adults, children, and infants in south and southeast Asia: results from two randomised, observer-blind, age de-escalation, phase 2 trials.

Bhutta ZA, Capeding MR, Bavdekar A, Marchetti E, Ariff S, Soofi SB, Anemona A, Habib MA, Alberto E, Juvekar S, Khan RM, Marhaba R, Ali N, Malubay N, Kawade A, Saul A, Martin LB, Podda A.

Lancet Infect Dis. 2013 Nov 27. doi:pii: S1473-3099(13)70241-X. 10.1016/S1473- 3099(13)70241-X. [Epub ahead of print] 24

PMID: 24290843 [PubMed - as supplied by publisher]

Related citations

Select item 24290842 64.

A conjugate vaccine against typhoid fever.

Park SE, Marks F.

Lancet Infect Dis. 2013 Nov 27. doi:pii: S1473-3099(13)70292-5. 10.1016/S1473- 3099(13)70292-5. [Epub ahead of print] No abstract available.

PMID: 24290842 [PubMed - as supplied by publisher]

Related citations

Select item 24290278 65.

Premature immune senescence during HIV-1 vertical infection relates with response to influenza vaccination.

Cagigi A, Rinaldi S, Di Martino A, Manno EC, Zangari P, Aquilani A, Cotugno N, Nicolosi L, Villani A, Bernardi S, Donatelli I, Pahwa S, Rossi P, Palma P.

J Allergy Clin Immunol. 2013 Nov 28. doi:pii: S0091-6749(13)01550-9. 10.1016/j.jaci.2013.10.003. [Epub ahead of print] No abstract available.

PMID: 24290278 [PubMed - as supplied by publisher]

Related citations

Select item 24289886 66.

Influenza Vaccinations: Older Adults' Decision-Making Process.

McIntyre A, Zecevic A, Diachun L.

Can J Aging. 2013 Dec 2:1-7. [Epub ahead of print]

PMID: 24289886 [PubMed - as supplied by publisher]

Related citations

Select item 24289658 67.

Antibody persistence 1 year after pandemic H1N1 2009 influenza vaccination and immunogenicity of subsequent seasonal influenza vaccine among adult organ transplant patients.

Felldin M, Andersson B, Studahl M, Svennerholm B, Friman V.

Transpl Int. 2013 Nov 8. doi: 10.1111/tri.12237. [Epub ahead of print]

PMID: 24289658 [PubMed - as supplied by publisher]

Related citations

Select item 24289628 68.

Awareness and Knowledge about Human Papillomavirus Infection and Vaccination among Women in UAE.

Ortashi O, Raheel H, Shalal M, Osman N.

Asian Pac J Cancer Prev. 2013;14(10):6077-80.

PMID: 24289628 [PubMed - in process] Free Article

Related citations

Select item 24289611 69.

In silico Design of Discontinuous Peptides Representative of B and T-cell Epitopes from HER2-ECD as Potential Novel Cancer Peptide Vaccines.

Manijeh M, Mehrnaz K, Violaine M, Hassan M, Abbas J, Mohammad R.

Asian Pac J Cancer Prev. 2013;14(10):5973-81.

PMID: 24289611 [PubMed - in process] Free Article

Related citations

Select item 24289225 70.

Acute chorea in a child receiving second dose of human papilloma virus vaccine.

Decio A, Balottin U, De Giorgis V, Veggiotti P.

Pediatr Allergy Immunol. 2013 Dec 1. doi: 10.1111/pai.12164. [Epub ahead of print] No abstract available.

PMID: 24289225 [PubMed - as supplied by publisher]

Related citations

Select item 24289031 71.

Novel expression of Haemonchus contortus vaccine candidate aminopeptidase H11 using the free-living nematode Caenorhabditis elegans.

Roberts B, Antonopoulos A, Haslam SM, Dicker AJ, McNeilly TN, Johnston SL, Dell A, Knox DP, Britton C.

Vet Res. 2013 Dec 1;44(1):111. [Epub ahead of print]

PMID: 24289031 [PubMed - as supplied by publisher] Free Article

Related citations

Select item 24288555 72.

BCG and BCG/DNAhsp65 Vaccinations Promote Protective Effects without Deleterious Consequences for Experimental Autoimmune Encephalomyelitis.

Zorzella-Pezavento SF, Guerino CP, Chiuso-Minicucci F, França TG, Ishikawa LL, Masson AP, Silva CL, Sartori A.

Clin Dev Immunol. 2013;2013:721383. doi: 10.1155/2013/721383. Epub 2013 Oct 29.

PMID: 24288555 [PubMed - in process] Free PMC Article

Related citations

Select item 24288554 73.

CD8 Knockout Mice Are Protected from Challenge by Vaccination with WR201, a Live Attenuated Mutant of Brucella melitensis.

Yingst SL, Izadjoo M, Hoover DL.

Clin Dev Immunol. 2013;2013:686919. doi: 10.1155/2013/686919. Epub 2013 Oct 28.

PMID: 24288554 [PubMed - in process] Free PMC Article

Related citations

Select item 24288207 74.

Cost Effectiveness of the New Pneumococcal Vaccines: A Systematic Review of European Studies. van de Vooren K, Duranti S, Curto A, Garattini L.

Pharmacoeconomics. 2013 Nov 28. [Epub ahead of print]

PMID: 24288207 [PubMed - as supplied by publisher]

Related citations

Select item 24288046 75.

Survey about tolerance of the AS03-adjuvanted H1N1 influenza vaccine in children with rheumatic diseases.

Sengler C, Niewerth M, Kallinich T, Nimtz-Talaska A, Haller M, Huppertz HI, Minden K.

Clin Rheumatol. 2013 Nov 28. [Epub ahead of print]

PMID: 24288046 [PubMed - as supplied by publisher]

Related citations

Select item 24287923 76.

Comparative genomic sequence analysis between a standard challenge strain and a vaccine strain of duck enteritis virus in China.

Yang C, Li Q, Li J, Zhang G, Li H, Xia Y, Yang H, Yu K.

Virus Genes. 2013 Nov 28. [Epub ahead of print]

PMID:

24287923 [PubMed - as supplied by publisher]

Related citations

Select item 24287838 77.

Influenza vaccine - for whom?

Haneberg B, Mamelund SE, Mjaaland S.

Tidsskr Nor Laegeforen. 2013 Nov 26;133(22):2376-2378. English, Norwegian. No abstract available.

PMID: 24287838 [PubMed - as supplied by publisher] Free Article

Related citations

Select item 24287585 78.

Development of novel DNA vaccine for VEGF in murine cancer model.

Kyutoku M, Nakagami H, Koriyama H, Tomioka H, Nakagami F, Shimamura M, Kurinami H, Zhengda P, Jo DH, Kim JH, Takakura N, Morishita R.

Sci Rep. 2013 Nov 29;3:3380. doi: 10.1038/srep03380.

PMID: 24287585 [PubMed - in process] Free PMC Article

Related citations

Select item 24287186 79.

Effect of pneumococcal Haemophilus influenzae protein D conjugate vaccine (PHiD- CV10) on outpatient antimicrobial purchases: a double-blind, cluster randomised phase 3-4 trial.

Palmu AA, Jokinen J, Nieminen H, Rinta-Kokko H, Ruokokoski E, Puumalainen T, Borys D, Lommel P, Traskine M, Moreira M, Schuerman L, Kilpi TM.

Lancet Infect Dis. 2013 Nov 25. doi:pii: S1473-3099(13)70338-4. 10.1016/S1473- 3099(13)70338-4. [Epub ahead of print]

PMID: 24287186 [PubMed - as supplied by publisher] 29

Related citations

Select item 24287057 80.

Recombinant vaccines against bluetongue virus.

Calvo-Pinilla E, Castillo-Olivares J, Jabbar T, Ortego J, de la Poza F, Marín-López A.

Virus Res. 2013 Nov 25. doi:pii: S0168-1702(13)00420-6. 10.1016/j.virusres.2013.11.013. [Epub ahead of print]

PMID: 24287057 [PubMed - as supplied by publisher]

Related citations

Select item 24287015 81.

What Parents and Adolescent Boys Want in School Vaccination Programs in the United States.

Shah PD, McRee AL, Reiter PL, Brewer NT.

J Adolesc Health. 2013 Nov 25. doi:pii: S1054-139X(13)00521-1. 10.1016/j.jadohealth.2013.09.022. [Epub ahead of print]

PMID: 24287015 [PubMed - as supplied by publisher]

Related citations

Select item 24286836 82.

System factors to explain 2009 pandemic H1N1 state vaccination rates for children and high-risk adults in US emergency response to pandemic.

Davila-Payan C, Swann J, Wortley PM.

Vaccine. 2013 Nov 25. doi:pii: S0264-410X(13)01535-1. 10.1016/j.vaccine.2013.11.018. [Epub ahead of print]

PMID: 24286836 [PubMed - as supplied by publisher]

Related citations

Select item 24286835 83.

Epithelial stem cells as mucosal antigen-delivering cells: A novel AIDS vaccine approach.

White R, Chenciner N, Bonello G, Salas M, Blancou P, Gauduin MC.

Vaccine. 2013 Nov 25. doi:pii: S0264-410X(13)01233-4. 10.1016/j.vaccine.2013.09.006. [Epub ahead of print]

PMID: 24286835 [PubMed - as supplied by publisher]

Related citations

Select item 24286781 84.

In addition to its antiviral and immunomodulatory properties, the zebrafish β-defensin 2 (zfBD2) is a potent viral DNA vaccine molecular adjuvant.

García-Valtanen P, Martinez-Lopez A, Ortega-Villaizan M, Perez L, Coll JM, Estepa A.

Antiviral Res. 2013 Nov 25. doi:pii: S0166-3542(13)00340-9. 10.1016/j.antiviral.2013.11.009. [Epub ahead of print]

PMID: 24286781 [PubMed - as supplied by publisher]

Related citations

Select item 24286709 85.

How can we increase seasonal influenza vaccine coverage in nursing home residents?

Michel JP.

J Am Med Dir Assoc. 2013 Dec;14(12):858-9. doi: 10.1016/j.jamda.2013.09.008. No abstract available.

PMID: 24286709 [PubMed - in process]

Related citations

Select item 24286478 86.

Multivalent paediatric allergy vaccines protect against allergic anaphylaxis in mice.

Waeckerle-Men Y, Liang Y, von Moos S, Kündig TM, Johansen P.

Clin Exp Allergy. 2013 Nov 28. doi: 10.1111/cea.12245. [Epub ahead of print]

PMID: 24286478 [PubMed - as supplied by publisher]

Related citations

Select item 24286311 87.

Therapeutic effect of a TM4SF5-specific peptide vaccine against colon cancer in a mouse model.

Kwon S, Kim YE, Park JA, Kim DS, Kwon HJ, Lee Y.

BMB Rep. 2013 Dec 1. doi:pii: 2436. [Epub ahead of print]

PMID: 24286311 [PubMed - as supplied by publisher] Free Article

Related citations

Select item 24286301 88.

Escherichia coli O26 in Feedlot Cattle: Fecal Prevalence, Isolation, Characterization, and Effects of an E. coli O157 Vaccine and a Direct-Fed Microbial.

Paddock ZD, Renter DG, Cull CA, Shi X, Bai J, Nagaraja TG.

Foodborne Pathog Dis. 2013 Nov 28. [Epub ahead of print]

PMID: 24286301 [PubMed - as supplied by publisher]

Related citations

Select item 24286291 89.

A scientific sequel to Stieg Larsson: relationship between Pandemrix - pandemic influenza vaccine - and the subsequent development of narcolepsy.

Fugger L, Steinman L.

J Intern Med. 2013 Nov 8. doi: 10.1111/joim.12158. [Epub ahead of print] No abstract available.

PMID: 24286291

[PubMed - as supplied by publisher]

Related citations

Select item 24286269 90.

Rituximab and abatacept but not tocilizumab impair antibody response to pneumococcal conjugate vaccine in patients with rheumatoid arthritis.

Crnkic Kapetanovic M, Saxne T, Jönsson G, Truedsson L, Geborek P.

Arthritis Res Ther. 2013 Oct 30;15(5):R171. doi: 10.1186/ar4358.

PMID: 24286269 [PubMed - in process]

Related citations

Select item 24285847 91.

A Paradigm Shift: Vaccine Induced Antibodies as an Immune Correlate of Protection against HSV-1 Genital Herpes.

Awasthi S, Friedman HM.

J Infect Dis. 2013 Nov 27. [Epub ahead of print] No abstract available.

PMID: 24285847 [PubMed - as supplied by publisher]

Related citations

Select item 24285844 92.

Correlate of Immune Protection Against HSV-1 Genital Disease in Vaccinated Women.

Belshe RB, Heineman TC, Bernstein DI, Bellamy AR, Ewell M, van der Most R, Deal CD.

J Infect Dis. 2013 Nov 27. [Epub ahead of print]

PMID: 24285844 [PubMed - as supplied by publisher]

Related citations

Select item 24285837 93.

Targeting CD137 Enhances Vaccine-Elicited Anti-Respiratory Syncytial Virus CD8+ T Cell Responses in Aged Mice.

Lee S, Mittler RS, Moore ML.

J Immunol. 2013 Nov 27. [Epub ahead of print]

PMID: 24285837 [PubMed - as supplied by publisher]

Related citations

Select item 24285816 94.

The absence of an important vaccine and diagnostic target in carriage- and disease- related nontypable Haemophilus influenzae.

Smith-Vaughan HC, Chang AB, Sarovich DS, Marsh RL, Grimwood K, Leach AJ, Morris PS, Price EP.

Clin Vaccine Immunol. 2013 Nov 27. [Epub ahead of print]

PMID: 24285816 [PubMed - as supplied by publisher]

Related citations

Select item 24285467 95.

Can building evidence move a persistent vaccine safety concern?

Feemster KA.

Pharmacoepidemiol Drug Saf. 2013 Dec;22(12):1271-3. doi: 10.1002/pds.3532. Epub 2013 Oct 15. No abstract available.

PMID: 24285467 [PubMed - in process]

Related citations

Select item 24285177 96.

HLA-DPB1 and anti-HBs titer kinetics in hepatitis B booster recipients who completed primary hepatitis B vaccination during infancy.

Wu TW, Chu CC, Chang Liao HW, Lin SK, Ho TY, Lin M, Lin HH, Wang LY.

Genes Immun. 2013 Nov 28. doi: 10.1038/gene.2013.62. [Epub ahead of print]

PMID: 24285177 [PubMed - as supplied by publisher]

Related citations

Select item 24284791 97.

Influenza vaccine response in adults exposed to perfluorooctanoate (PFOA) and perfluorooctanesulfonate (PFOS).

C L, M I L, A M C, V J J, G R B, F G B, T F.

Toxicol Sci. 2013 Nov 27. [Epub ahead of print]

PMID: 24284791 [PubMed - as supplied by publisher]

Related citations

Select item 24284721 98.

TB vaccine failure was predictable.

Beverley P.

Nature. 2013 Nov 28;503(7477):469. doi: 10.1038/503469e. No abstract available.

PMID: 24284721 [PubMed - in process]

Related citations

Select item 24284413 99.

Efficacy of Hepatitis A Vaccination and Factors Impacting on Seroconversion in Patients with Inflammatory Bowel Disease.

Park SH, Yang SK, Park SK, Kim JW, Yang DH, Jung KW, Kim KJ, Ye BD, Byeon JS, Myung SJ, Kim JH.

Inflamm Bowel Dis. 2013 Nov 26. [Epub ahead of print]

PMID: 24284413 [PubMed - as supplied by publisher]

Related citations

Select item 24284411 100.

Vaccination for safe travel to India.

Mehta B, Jindal H, Bhatt B, Kumar V, Singh Choudhary S.

Hum Vaccin Immunother. 2013 Nov 27;10(4). [Epub ahead of print]

PMID: 24284411 [PubMed - as supplied by publisher]

Related citations

Select item 24284410 101.

A reduction in chronic hepatitis B virus infection prevalence among children in Vietnam demonstrates the importance of vaccination.

Nguyen TH, Huong VM, Nguyen C, Nguyen LH, Toda K, Nguyen TN, Dao S, Wannemuehler KA, Hennessey KA.

Vaccine. 2013 Nov 24. doi:pii: S0264-410X(13)01503-X. 10.1016/j.vaccine.2013.11.004. [Epub ahead of print]

PMID: 24284410 [PubMed - as supplied by publisher]

Related citations

Select item 24284325 102.

Protection Provided by an HSV-2 Glycoprotein C and D Subunit Antigen Vaccine against Genital HSV-2 Infection in HSV-1 Seropositive Guinea Pigs.

Awasthi S, Balliet JW, Flynn JA, Lubinski JM, Shaw CE, Distefano DJ, Cai M, Brown M, Smith JF, Kowalski R, Swoyer R, Galli J, Copeland V, Rios S, Davidson RC, Salnikova M, Kingsley S, Bryan J, Casimiro DR, Friedman HM.

J Virol. 2013 Nov 27. [Epub ahead of print]

PMID: 24284325 [PubMed - as supplied by publisher]

Related citations

Select item 24284319 103.

In Vivo Electroporation of Minicircle DNA as a Novel Method of Vaccine Delivery to Enhance HIV-1-Specific Immune Responses.

Wang Q, Jiang W, Chen Y, Liu P, Sheng C, Chen S, Zhang H, Pan C, Gao S, Huang W.

J Virol. 2013 Nov 27. [Epub ahead of print]

PMID: 24284319 [PubMed - as supplied by publisher]

Related citations

Select item 24284281 104.

Subdeltoid/subacromial bursitis associated with influenza vaccination.

Cook IF.

Hum Vaccin Immunother. 2013 Nov 27;10(3). [Epub ahead of print]

PMID: 24284281 [PubMed - as supplied by publisher]

Related citations

Select item 24284225 105.

[Preliminary observation on antitumor effect of HPV58 composite DNA vaccine].

Wang H, Yu JY, Li L.

Zhonghua Fu Chan Ke Za Zhi. 2013 Jul;48(7):523-7. Chinese.

PMID: 24284225 [PubMed - in process]

Related citations

Select item 24284038 106.

Modelled evaluation of multi-component meningococcal vaccine (Bexsero®) for the prevention of invasive meningococcal disease in infants and adolescents in the UK.

Huels J, Clements KM, McGarry LJ, Hill GJ, Wassil J, Kessabi S.

Epidemiol Infect. 2013 Nov 28:1-13. [Epub ahead of print]

PMID: 24284038 [PubMed - as supplied by publisher]

Related citations

Select item 24283990 107.

CMV vaccine: phase II clinical trial results.

Rieder F, Steininger C.

Clin Microbiol Infect. 2013 Nov 27. doi: 10.1111/1469-0691.12449. [Epub ahead of print]

PMID: 24283990 [PubMed - as supplied by publisher]

Related citations

Select item 24283842 108.

Employing an IL-23 p19 vaccine to block IL-23 ameliorates chronic murine colitis.

Guan Q, Burtnick HA, Qing G, Weiss CR, Ma AG, Ma Y, Warrington RJ, Peng Z.

Immunotherapy. 2013 Dec;5(12):1313-22. doi: 10.2217/imt.13.141.

PMID: 24283842 [PubMed - in process]

Related citations

Select item 24283841 109.

Autologous and allogenic systems of HIV expansion: what is the better choice for clinical application in therapeutic vaccine?

Silva LT, Pontillo A, da Silva WC, Almeida Ad, Duarte AJ, Oshiro TM.

Immunotherapy. 2013 Dec;5(12):1305-11. doi: 10.2217/imt.13.136.

PMID: 24283841 [PubMed - in process]

Related citations

Select item 24283444 110.

Erythema multiforme after rabies vaccination.

Wiwanitkit S, Wiwanitkit V.

Pediatr Dermatol. 2013 Nov;30(6):e299. doi: 10.1111/pde.12145. No abstract available.

PMID: 24283444 [PubMed - in process]

Related citations

Select item 24283258 111.

The combination of attenuated Newcastle disease (ND) vaccine with rHVT-ND vaccine at 1 day old is more protective against ND virus challenge than when combined with inactivated ND vaccine.

Rauw F, Gardin Y, Palya V, van den Berg T, Lambrecht B.

Avian Pathol. 2013 Nov 28. [Epub ahead of print]

PMID: 24283258 [PubMed - as supplied by publisher]

Related citations

Select item 24283256 112.

Critical Research Concepts in TB Vaccine Development.

Delogu G, Manganelli R, Brennan MJ.

Clin Microbiol Infect. 2013 Nov 27. doi: 10.1111/1469-0691.12460. [Epub ahead of print]

PMID: 24283256 [PubMed - as supplied by publisher]

Related citations

Select item 24283223 113.

The quest for an HIV-1 vaccine--moving forward.

Barouch DH.

N Engl J Med. 2013 Nov 28;369(22):2073-6. doi: 10.1056/NEJMp1312711. No abstract available.

PMID: 24283223 [PubMed - in process] Free Article

Related citations

Select item 24283136 114.

Effect of spray Escherichia coli vaccine on the immunity of poultry.

Fernandes Filho T, Fávaro C Jr, Ingberman M, Beirão BC, Inoue A, Gomes L, Caron LF.

Avian Dis. 2013 Sep;57(3):671-6.

PMID: 24283136 [PubMed - in process]

Related citations

Select item 24283127 115.

Protecting chickens against coccidiosis in floor pens by administering Eimeria oocysts using gel beads or spray vaccination.

Jenkins MC, Parker C, O'Brien C, Persyn J, Barlow D, Miska K, Fetterer R.

Avian Dis. 2013 Sep;57(3):622-6.

PMID: 24283127 [PubMed - in process]

Related citations

AMEDEO - Vaccines Publicaciones (02 - 12 - 2013): 39 artículos nuevos.

Vacunas Meningococo (Neisseria meningitidis)

29. MARSHALL H, Clarke M, Sullivan T. Parental and community acceptance of the benefits and risks associated with meningococcal B vaccines. Vaccine. 2013 Nov 20. pii: S0264-410X(13)01563. PubMed: www.amedeo.com/p2.php?id=24269618&s=vac&pm=badc2a9eebb0fad ABSTRACT available

Share: http://m.amedeo.com/24269618

Vacunas BCG – ONCO BCG (Mycobacterium bovis)

11. HARRIS SA, Meyer J, Satti I, Marsay L, et al. Evaluation of a human BCG challenge model to assess anti-mycobacterial immunity induced by BCG and a candidate TB vaccine, MVA85A, alone and in combination. J Infect Dis. 2013. PubMed: www.amedeo.com/p2.php?id=24273174&s=vac&pm=badc2a9eebb0fad ABSTRACT available Share: http://m.amedeo.com/24273174

32. DEAN G, Whelan A, Clifford D, Salguero JF, et al. Comparison of the immunogenicity and protection against bovine tuberculosis following immunization by BCG-priming and boosting with adenovirus or protein based vaccines. Vaccine. 2013 Nov 19. pii: S0264-410X(13)01566. PubMed: www.amedeo.com/p2.php?id=24269321&s=vac&pm=badc2a9eebb0fad ABSTRACT available Share: http://m.amedeo.com/24269321

Vacunas Neumococo (Streptococcus pneumoniae)

10. GOUNDER PP, Bruce MG, Bruden DJ, Singleton RJ, et al. Effect of the 13-valent Pneumococcal Conjugate Vaccine on Nasopharyngeal Colonization by Streptococcus pneumoniae -- Alaska, 2008-2012. J Infect Dis. 2013. PubMed: www.amedeo.com/p2.php?id=24273178&s=vac&pm=badc2a9eebb0fad ABSTRACT available Share: http://m.amedeo.com/24273178

18. CAEYMAEX L, Varon E, Levy C, Bechet S, et al. Characteristics and Outcomes of Acute Otitis Media in Children Carrying Streptococcus pneumoniae or Haemophilus influenzae in Their Nasopharynx as a Single Otopathogen after Introduction of the Heptavalent Pneumococcal Conjugate Vaccine. Pediatr Infect Dis J. 2013. PubMed: www.amedeo.com/p2.php?id=24263220&s=vac&pm=badc2a9eebb0fad ABSTRACT available Share: http://m.amedeo.com/24263220

37. OCHOA-GONDAR O, Vila-Corcoles A, Rodriguez-Blanco T, de Diego-Cabanes C, et al. Evaluating the clinical effectiveness of pneumococcal vaccination in preventing myocardial infarction: The CAPAMIS study, three-year follow-up. Vaccine. 2013 Nov 18. pii: S0264-410X(13)01534. PubMed: www.amedeo.com/p2.php?id=24262314&s=vac&pm=badc2a9eebb0fad ABSTRACT available Share: http://m.amedeo.com/24262314

Vacuna Tosferina (Bordetella pertussis)

1. TRAVASSO C. Indian academy recommends whole cell pertussis vaccine for primary vaccination. BMJ. 2013;347:f7059. PubMed: www.amedeo.com/p2.php?id=24277630&s=vac&pm=badc2a9eebb0fad Share: http://m.amedeo.com/24277630

Vacunas, otras

2. THOMPSON MG, Li DK, Shifflett P, Sokolow LZ, et al. Effectiveness of seasonal trivalent influenza vaccine for preventing influenza virus illness among pregnant women: a population-based case-control study during the 2010-2011 and 2011-2012 influenza seasons. Clin Infect Dis. 2013. PubMed: www.amedeo.com/p2.php?id=24280090&s=vac&pm=badc2a9eebb0fad ABSTRACT available Share: http://m.amedeo.com/24280090

3. PAYNE DC, Baggs J, Zerr DM, Klein NP, et al. Protective Association Between Rotavirus Vaccination and Childhood Seizures in the Year Following Vaccination in US Children. Clin Infect Dis. 2013. PubMed: www.amedeo.com/p2.php?id=24265355&s=vac&pm=badc2a9eebb0fad ABSTRACT available Share: http://m.amedeo.com/24265355

4. WEINBERG GA. Unexpected Benefits of Immunization: Rotavirus Vaccines Reduce Childhood Seizures. Clin Infect Dis. 2013. PubMed: www.amedeo.com/p2.php?id=24265354&s=vac&pm=badc2a9eebb0fad

Share: http://m.amedeo.com/24265354

5. LEE S, Mittler RS, Moore ML. Targeting CD137 Enhances Vaccine-Elicited Anti-Respiratory Syncytial Virus CD8+ T Cell Responses in Aged Mice. J Immunol. 2013. PubMed: www.amedeo.com/p2.php?id=24285837&s=vac&pm=badc2a9eebb0fad ABSTRACT available Share: http://m.amedeo.com/24285837

6. AWASTHI S, Friedman HM. A Paradigm Shift: Vaccine Induced Antibodies as an Immune Correlate of Protection against HSV-1 Genital Herpes. J Infect Dis. 2013. PubMed: www.amedeo.com/p2.php?id=24285847&s=vac&pm=badc2a9eebb0fad

Share: http://m.amedeo.com/24285847

7. BELSHE RB, Heineman TC, Bernstein DI, Bellamy AR, et al. Correlate of Immune Protection Against HSV-1 Genital Disease in Vaccinated Women. J Infect Dis. 2013. PubMed: www.amedeo.com/p2.php?id=24285844&s=vac&pm=badc2a9eebb0fad ABSTRACT available Share: http://m.amedeo.com/24285844

8. MUHSEN K, Pasetti MF, Reymann MK, Graham DY, et al. Helicobacter pylori infection affects immune responses following vaccination of typhoid-naive U.S. adults with attenuated Salmonella Typhi oral vaccine CVD

908-htrA. J Infect Dis. 2013. PubMed: www.amedeo.com/p2.php?id=24273182&s=vac&pm=badc2a9eebb0fad ABSTRACT available Share: http://m.amedeo.com/24273182

9. TOFT L, Storgaard M, Muller M, Sehr P, et al. Comparison of the Immunogenicity and Reactogenicity of Cervarix(R) and Gardasil(R) Human Papillomavirus Vaccines in HIV-infected Adults: A Randomized, Double-Blind, Clinical Trial. J Infect Dis. 2013. PubMed: www.amedeo.com/p2.php?id=24273179&s=vac&pm=badc2a9eebb0fad ABSTRACT available Share: http://m.amedeo.com/24273179

12. MISSTEAR K, McNeela EA, Murphy AG, Geoghegan JA, et al. Targeted nasal vaccinationprovides antibody independent protection againstStaphylococcus aureus. J Infect Dis. 2013. PubMed: www.amedeo.com/p2.php?id=24273045&s=vac&pm=badc2a9eebb0fad ABSTRACT available Share: http://m.amedeo.com/24273045

13. CRANSTON RD. Young Gay Men and the Quadrivalent Human Papillomavirus Vaccine - Much to Gain (and Lose). J Infect Dis. 2013. PubMed: www.amedeo.com/p2.php?id=24265443&s=vac&pm=badc2a9eebb0fad

Share: http://m.amedeo.com/24265443

14. SHAH KV. A case for immunization of HPV 6/11-infected pregnant women with the quadrivalent HPV vaccine to prevent juvenile-onset laryngeal papilloma. J Infect Dis. 2013. PubMed: www.amedeo.com/p2.php?id=24265442&s=vac&pm=badc2a9eebb0fad ABSTRACT available

Share: http://m.amedeo.com/24265442

15. AWASTHI S, Balliet JW, Flynn JA, Lubinski JM, et al. Protection Provided by an HSV-2 Glycoprotein C and D Subunit Antigen Vaccine against Genital HSV-2 Infection in HSV-1 Seropositive Guinea Pigs. J Virol. 2013. PubMed: www.amedeo.com/p2.php?id=24284325&s=vac&pm=badc2a9eebb0fad ABSTRACT available Share: http://m.amedeo.com/24284325

16. WANG Q, Jiang W, Chen Y, Liu P, et al. In Vivo Electroporation of Minicircle DNA as a Novel Method of Vaccine Delivery to Enhance HIV-1-Specific Immune Responses. J Virol. 2013. PubMed: www.amedeo.com/p2.php?id=24284319&s=vac&pm=badc2a9eebb0fad ABSTRACT available Share: http://m.amedeo.com/24284319

17. BAROUCH DH. The Quest for an HIV-1 Vaccine - Moving Forward. N Engl J Med. 2013;369:2073-6. PubMed: www.amedeo.com/p2.php?id=24283223&s=vac&pm=badc2a9eebb0fad ABSTRACT available Share: http://m.amedeo.com/24283223

19. NGUYEN TH, Huong VM, Nguyen C, Nguyen LH, et al. A reduction in chronic hepatitis B virus infection prevalence among children in Vietnam demonstrates the importance of vaccination. Vaccine. 2013 Nov 24. pii: S0264-410X(13)01503. PubMed: www.amedeo.com/p2.php?id=24284410&s=vac&pm=badc2a9eebb0fad ABSTRACT available Share: http://m.amedeo.com/24284410

20. FIEBELKORN AP, Seward JF, Orenstein W. A global perspective of vaccination of healthcare personnel against measles: Systematic review. Vaccine. 2013 Nov 23. pii: S0264-410X(13)01504. PubMed: www.amedeo.com/p2.php?id=24280280&s=vac&pm=badc2a9eebb0fad ABSTRACT available Share: http://m.amedeo.com/24280280

21. GIL-PRIETO R, Walter S, Gonzalez-Escalada A, Garcia-Garcia L, et al.

Different vaccination strategies in Spain and its impact on severe varicella and zoster. Vaccine. 2013 Nov 22. pii: S0264-410X(13)01525. PubMed: www.amedeo.com/p2.php?id=24275483&s=vac&pm=badc2a9eebb0fad ABSTRACT available Share: http://m.amedeo.com/24275483

22. BORNSTEIN J, Fisher WA, Ginsberg GM, Shavit O, et al. Screening for cervical cancer and human papillomavirus vaccination in Israel: recommendations. Vaccine. 2013;31 Suppl 8:I58-I60. PubMed: www.amedeo.com/p2.php?id=24229721&s=vac&pm=badc2a9eebb0fad

Share: http://m.amedeo.com/24229721

23. FISHER WA, Laniado H, Shoval H, Hakim M, et al. Barriers to human papillomavirus vaccine acceptability in Israel. Vaccine. 2013;31 Suppl 8:I53-I57. PubMed: www.amedeo.com/p2.php?id=24229720&s=vac&pm=badc2a9eebb0fad ABSTRACT available Share: http://m.amedeo.com/24229720

24. SCHEJTER E, Bornstein J, Siegler E. Cervical cancer screening, human papillomavirus vaccination practices and current infrastructure in Israel. Vaccine. 2013;31 Suppl 8:I42-I45. PubMed: www.amedeo.com/p2.php?id=24229718&s=vac&pm=badc2a9eebb0fad ABSTRACT available Share: http://m.amedeo.com/24229718

25. ROJAS JM, Moreno H, Garcia A, Ramirez JC, et al. Two replication-defective adenoviral vaccine vectors for the induction of immune responses to PPRV. Vaccine. 2013 Nov 20. pii: S0264-410X(13)01550. PubMed: www.amedeo.com/p2.php?id=24269622&s=vac&pm=badc2a9eebb0fad ABSTRACT available Share: http://m.amedeo.com/24269622

26. JIMENEZ-GARCIA R, Rodriguez-Rieiro C, Hernandez-Barrera V, Carrasco Garrido P, et al. Negative trends from 2008/9 to 2011/12 seasons in influenza vaccination coverages among high risk subjects and health care workers in Spain. Vaccine. 2013 Nov 20. pii: S0264-410X(13)01561. PubMed: www.amedeo.com/p2.php?id=24269621&s=vac&pm=badc2a9eebb0fad ABSTRACT available Share: http://m.amedeo.com/24269621

27. AFONSO N, Kavanagh M, Swanberg S. Improvement in attitudes toward influenza vaccination in medical students following an integrated curricular intervention. Vaccine. 2013 Nov 20. pii: S0264-410X(13)01564. PubMed: www.amedeo.com/p2.php?id=24269620&s=vac&pm=badc2a9eebb0fad ABSTRACT available

Share: http://m.amedeo.com/24269620

28. MILLS B, Fensterheim L, Taitel M, Cannon A, et al. Pharmacist-led Tdap vaccination of close contacts of neonates in a women's hospital. Vaccine. 2013 Nov 20. pii: S0264-410X(13)01552. PubMed: www.amedeo.com/p2.php?id=24269619&s=vac&pm=badc2a9eebb0fad ABSTRACT available Share: http://m.amedeo.com/24269619

30. PLEIDRUP J, Dalgaard TS, Norup LR, Permin A, et al. Ascaridia galli infection influences the development of both humoral and cell-mediated immunity after Newcastle Disease vaccination in chickens. Vaccine. 2013 Nov 20. pii: S0264-410X(13)01551. PubMed: www.amedeo.com/p2.php?id=24269617&s=vac&pm=badc2a9eebb0fad ABSTRACT available Share: http://m.amedeo.com/24269617

31. BRAECKMAN T, Lernout T, Top G, Paeps A, et al. Assessing vaccination coverage in infants, survey studies versus the Flemish immunisation register: Achieving the best of both worlds. Vaccine. 2013 Nov 20. pii: S0264-410X(13)01562. PubMed: www.amedeo.com/p2.php?id=24269616&s=vac&pm=badc2a9eebb0fad ABSTRACT available Share: http://m.amedeo.com/24269616

33. VON GIERKE L, Wicker S. Flu vaccination goes mobile. Vaccine. 2013 Nov 19. pii: S0264-410X(13)01529. PubMed: www.amedeo.com/p2.php?id=24269320&s=vac&pm=badc2a9eebb0fad

Share: http://m.amedeo.com/24269320

34. OPRIESSNIG T, Gerber PF, Xiao CT, Mogler M, et al. Commercial vaccines based on PCV2a and experimental vaccines based on a variant

46 mPCV2b are both effective in protecting pigs against challenge with a 2013 U.S. variant mPCV2b strain. Vaccine. 2013 Nov 19. pii: S0264-410X(13)01527. PubMed: www.amedeo.com/p2.php?id=24269319&s=vac&pm=badc2a9eebb0fad ABSTRACT available Share: http://m.amedeo.com/24269319

35. RODRIGUEZ-BARRAQUER I, Mier-Y-Teran-Romero L, Schwartz IB, Burke DS, et al. Potential opportunities and perils of imperfect dengue vaccines. Vaccine. 2013 Nov 19. pii: S0264-410X(13)01537. PubMed: www.amedeo.com/p2.php?id=24269318&s=vac&pm=badc2a9eebb0fad ABSTRACT available Share: http://m.amedeo.com/24269318

36. ABHINAY G, Dessain S, Srikanth A, Senthilkumar RL, et al. A novel site-II directed glycoprotein estimation ELISA to aid rabies vaccine manufacture for veterinary and human use. Vaccine. 2013 Nov 18. pii: S0264-410X(13)01543. PubMed: www.amedeo.com/p2.php?id=24262315&s=vac&pm=badc2a9eebb0fad ABSTRACT available Share: http://m.amedeo.com/24262315

38. KLAUSBERGER M, Wilde M, Palmberger D, Hai R, et al. One-shot vaccination with an insect cell-derived low-dose influenza A H7 virus-like particle preparation protects mice against H7N9 challenge. Vaccine. 2013 Nov 18. pii: S0264-410X(13)01553. PubMed: www.amedeo.com/p2.php?id=24262313&s=vac&pm=badc2a9eebb0fad ABSTRACT available Share: http://m.amedeo.com/24262313

39. TAFURI S, Gallone MS, Cappelli MG, Prato R, et al. Addressing the anti-vaccination movement and the role of HCWs. Vaccine. 2013 Nov 18. pii: S0264-410X(13)01505. PubMed: www.amedeo.com/p2.php?id=24262311&s=vac&pm=badc2a9eebb0fad ABSTRACT available Share: http://m.amedeo.com/24262311

PATENTES

United States Patent and Trademark Office (USPTO)

Estrategia de búsqueda “vaccine” en título y abstract

(ABST/vaccine AND ISD/20131126->20131206): 8 patentes recuperadas.

Vacuna Tuberculosis (Mycobacterium tuberculosis)

5 8,591,918 Mycobacterial mutants inducing IL-12

Vacunas, otras

PAT. Title NO.

1 8,597,662 Vaccine for protection against Lawsonia intracellularis

2 8,597,651 Monomeric VHH domain derived from anti-VP6 camelid antibodies, dimeric domain, immunisation method, rotavirus detection method, composition,

prevention and treatment methods for rotavirus infections

3 8,592,197 Functional influenza virus-like particles (VLPs)

4 8,592,196 Modified influenza virus

5 8,591,918 Mycobacterial mutants inducing IL-12

6 8,591,917 Ganglioside based vaccine compositions for subcutaneous administration

7 8,591,915 Plant-derived vaccines against respiratory syncytial virus

8 8,591,890 Using heat shock proteins to improve the therapeutic benefit of a non-

vaccine treatment modality

European Patent Office (EPO)

Acumulado entre el 26 de noviembre y el 6 de diciembre de

2013: 18 patentes recuperadas.

Vacunas Neumococo (Streptococcus pneumoniae)

6. Immunogenic composition for infants comprising a multivalent streptococcus pneumoniae vaccine and its use

Publication info: IL192084 (A) 2013-11-28

Vacuna Tuberculosis (Mycobacterium tuberculosis)

10. METHOD FOR ATTENUATING A BACTERIUM OF THE MYCOBACTERIUM TUBERCULOSIS COMPLEX FOR PRODUCING A TUBERCULOSIS VACCINE

Publication info: WO2013175103 (A1) 2013-11-28

Adyuvantes

12. Method of Preparing an Immunologically-Active Adjuvant-Bound Dried Vaccine Composition

Publication info: US2013315966 (A1) 2013-11-28

Vacunas, otras

1. SCHMALLENBERG VIRUS (SBV) VACCINE, METHODS OF PRODUCTION, AND USES THEREOF

Publication info:

US2013323277 (A1) 2013-12-05 2. HERPES SIMPLEX VIRUS VACCINE

Publication info:

WO2013180967 (A1) 2013-12-05 3. TUMOR VACCINE AND PREPARATION METHOD THEREOF

Publication info:

WO2013178079 (A1) 2013-12-05 4. POLYPEPTIDE FOR TREATING ALZHEIMER'S DISEASE AND GENETIC VACCINE

Publication info:

WO2013177922 (A1) 2013-12-05 5. West nile virus vaccine

Publication info:

IL202978 (A) 2013-11-28 6. Immunogenic composition for infants comprising a multivalent streptococcus pneumoniae vaccine and its use

Publication info:

IL192084 (A) 2013-11-28 7. EMULSION VACCINE COMPOSITIONS COMPRISING ANTIGEN AND ADJUVANT IN THE AQUEOUS PHASE

Publication info:

SI2164510 (T1) 2013-11-29 8. INFLUENZA VACCINE CONSTRUCTS

Publication info:

WO2013177444 (A2) 2013-11-28 9. VACCINE

Publication info:

WO2013175207 (A1) 2013-11-28 10. METHOD FOR ATTENUATING A BACTERIUM OF THE MYCOBACTERIUM TUBERCULOSIS COMPLEX FOR PRODUCING A TUBERCULOSIS VACCINE

Publication info:

WO2013175103 (A1) 2013-11-28 11. COMPLEMENT COMPONENT C5A- BASED VACCINE

Publication info:

WO2013174920 (A1) 2013-11-28 12. Method of Preparing an Immunologically- Active Adjuvant-Bound Dried Vaccine Composition

Publication info:

US2013315966 (A1) 2013-11-28 13. VACCINE COMPOSITION AGAINST STREPTOCOCCUS PYOGENES INFECTION

Publication info:

US2013315946 (A1) 2013-11-28 14. VACCINE ANTIGENS THAT DIRECT IMMUNITY TO CONSERVED EPITOPES

Publication info:

US2013315929 (A1) 2013-11-28 15. NEWCASTLE DISEASE VIRUS AND THE USE THEREOF AS A VACCINE

Publication info:

US2013315956 (A1) 2013-11-28 16. RESPIRATORY SYNCYTIAL VIRUS VACCINE

Publication info:

US2013315916 (A1) 2013-11-28 17. METHOD FOR IMPROVING THE PRODUCTION OF INFLUENZA VIRUSES AND VACCINE SEEDS

Publication info:

US2013315954 (A1) 2013-11-28 18. ANIMAL MODEL FOR THE EVALUATION OF THE EFFICACY OF AN HIV VACCINE

Publication info: US2013316326 (A1) 2013-11-28

TABLAS DE CONTENIDO

Revista Vaccine

Tabla de Contenidos. Volume 31, Issue 51, Pages 6041 – 6160 (9 December 2013).

1. Editorial Board

Pages CO2

Editorial

2. Are Impact Factors corrupting truth and utility in biomedical research?

Pages 6041-6042 Andreas Suhrbier, Gregory A. Poland

Brief report

3. Potential of a sequence-based antigenic distance measure to indicate equine influenza vaccine strain efficacy

Pages 6043-6045 Janet M. Daly, Debra Elton

Reviews

4. The role of health economic analyses in vaccine decision making Review Article

Pages 6046-6049 Steven Black

5. Using solar-powered refrigeration for vaccine storage where other sources of reliable electricity are inadequate or costly Review Article

Pages 6050-6057 Steve McCarney, Joanie Robertson, Juliette Arnaud, Kristina Lorenson, John Lloyd

Original papers

6. Coverage and cost of a large oral cholera vaccination program in a high-risk cholera endemic urban population in Dhaka, Bangladesh Original Research Article

Pages 6058-6064 Iqbal Ansary Khan, Amit Saha, Fahima Chowdhury, Ashraful Islam Khan, Md Jasim Uddin, Yasmin A. Begum, Baizid Khoorshid Riaz, Sanjida Islam, Mohammad Ali, Stephen P. Luby, John D. Clemens, Alejandro Cravioto, Firdausi Qadri

7. Protective immunity induced by a recombinant BCG vaccine encoding the cyclophilin gene of Toxoplasma gondii Original Research Article

Pages 6065-6071 Qinlei Yu, Xiangsheng Huang, Pengtao Gong, Qian Zhang, Jianhua Li, Guocai Zhang, Ju Yang, He Li, Nan Wang, Xichen Zhang

8. Cost-effectiveness of a new rotavirus vaccination program in Pakistan: A decision tree model Original Research Article

Pages 6072-6078 Hiten D. Patel, Eric T. Roberts, Dagna O. Constenla

9. Immunogenicity of a recombinant measles HIV-1 subtype C vaccine Original Research Article

Pages 6079-6086 Richard Stebbings, Bo Li, Clarisse Lorin, Marguerite Koutsoukos, Michèle Février, Edward T. Mee, Mark Page, Neil Almond, Frédéric Tangy, Gérald Voss

10. Evaluation of several approaches to immunize parents of neonates against B. pertussis Original Research Article

Pages 6087-6091 Julie Frère, Philippe De Wals, Philippe Ovetchkine, Léna Coïc, François Audibert, Bruce Tapiero

11. Chikungunya virus-like particles are more immunogenic in a lethal AG129 mouse model compared to glycoprotein E1 or E2 subunits Original Research Article

Pages 6092-6096 Stefan W. Metz, Byron E. Martina, Petra van den Doel, Corinne Geertsema, Albert D. Osterhaus, Just M. Vlak, Gorben P. Pijlman

12. Preclinical immunogenicity and functional activity studies of an A + W meningococcal outer membrane vesicle (OMV) vaccine and comparisons with existing meningococcal conjugate- and polysaccharide vaccines Original Research Article

Pages 6097-6106 G. Tunheim, M. Arnemo, L.M. Næss, Å.K. Fjeldheim, L. Nome, K. Bolstad, A. Aase, A. Mandiarote, H. González, D. González, L. García, D. Cardoso, G.

Norheim, E. Rosenqvist

13. The influence of antigen targeting to sub-cellular compartments on the anti- allergic potential of a DNA vaccine Original Research Article

Pages 6113-6121 Esther E. Weinberger, Almedina Isakovic, Sandra Scheiblhofer, Christina Ramsauer, Katrin Reiter, Cornelia Hauser-Kronberger, Josef Thalhamer, Richard Weiss

14. The comparative effectiveness of adjuvanted and unadjuvanted trivalent inactivated influenza vaccine (TIV) in the elderly Original Research Article

Pages 6122-6128 P.G. Van Buynder, S. Konrad, J.L. Van Buynder, E. Brodkin, M. Krajden, G. Ramler, M. Bigham

15. The vaccine candidate BLSOmp31 protects mice against Brucella canis infection Original Research Article

Pages 6129-6135 Maria Clausse, Alejandra G. Díaz, Giselle Ghersi, Vanesa Zylberman, Juliana Cassataro, Guillermo H. Giambartolomei, Fernando A. Goldbaum, Silvia M. Estein

16. Safety and immunogenicity of a glycoprotein D genital herpes vaccine in healthy girls 10–17 years of age: Results from a randomised, controlled, double-blind trial Original Research Article

Pages 6136-6143 xxx, The HSV-040 Study Group

17. Maternal antibody induced by recombinant gp85 protein vaccine adjuvanted with CpG-ODN protects against ALV-J early infection in chickens Original Research Article

Pages 6144-6149 Wenwen Dou, Hongmei Li, Ziqiang Cheng, Peng Zhao, Jianzhu Liu, Zhizhong Cui, Haigang Liu, Weifang Jing, Huijun Guo

18. Serotype distribution of Streptococcus pneumoniae isolated from patients with invasive pneumococcal disease in Brazil before and after ten- pneumococcal conjugate vaccine implementation Original Research Article

Pages 6150-6154 Silvia R. dos Santos, Lilian F. Passadore, Elizabeth H. Takagi, Cristiane M. Fujii, Cristina R.M. Yoshioka, Alfredo E. Gilio, Marina B. Martinez

Japanese Society for Vaccinology paper

19. Long-term clinical studies of varicella vaccine at a regional hospital in Japan and proposal for a varicella vaccination program Review Article

Pages 6155-6160 Takao Ozaki

New Articles in Press, 26 November-2 December 2013.

1. Vaccination benefits and cost-sharing policy for non-institutionalized adult Medicaid enrollees Original Research Article

Available online 27 November 2013 Alexandra M. Stewart, Megan C. Lindley, Kristen H.M. Chang, Marisa A. Cox

2. Engineered Lactobacillus rhamnosus GG expressing IgG-binding domains of protein G: Capture of hyperimmune bovine colostrum antibodies and protection against diarrhea in a mouse pup rotavirus infection model Original Research Article

Available online 27 November 2013 Gökçe Günaydın, Ran Zhang, Lennart Hammarström, Harold Marcotte

3. DNA vaccination against a fish rhabdovirus promotes an early chemokine- related recruitment of B cells to the muscle Original Research Article

Available online 27 November 2013 Rosario Castro, Susana Martínez-Alonso, Uwe Fischer, Neila Álvarez de Haro, Verónica Soto-Lampe, Tiehui Wang, Christopher J. Secombes, Niels Lorenzen, Ellen Lorenzen, Carolina Tafalla

4. A dual vaccine candidate against norovirus and hepatitis E virus Original Research Article

Available online 27 November 2013 Leyi Wang, Dianjun Cao, Chao Wei, Xiang-Jin Meng, Xi Jiang, Ming Tan

5. Memory CD8+ T cells elicited by HIV-1 lipopeptide vaccines display similar phenotypic profiles but differences in term of magnitude and multifunctionality compared with FLU- or EBV-specific memory T cells in humans Original Research Article

Available online 27 November 2013 Suzanne Figueiredo, Benedicte Charmeteau, Mathieu Surenaud, Dominique Salmon, Odile Launay, Jean-Gérard Guillet, Anne Hosmalin, Hanne Gahery

6. Examining the views of key stakeholders regarding the provision of occupational influenza vaccination for healthcare workers in Australia Original Research Article

Available online 27 November 2013 Yi Chen Lim, Holly Seale

7. A monoclonal antibody that recognizes the E domain of staphylococcal protein A Original Research Article

Available online 27 November 2013 Hwan Keun Kim, Carla Emolo, Dominique Missiakas, Olaf Schneewind

8. Probiotics reduce symptoms of antibiotic use in a hospital setting: A randomized dose response study Original Research Article

Available online 26 November 2013 Arthur C. Ouwehand, Cai DongLian, Xu Weijian, Morgan Stewart, Jiayi Ni, Tad Stewart, Larry E. Miller

9. Impact of malaria and helminth infections on immunogenicity of the human papillomavirus-16/18 AS04-adjuvanted vaccine in Tanzania Original Research Article

Available online 26 November 2013 Joelle Brown, Kathy Baisley, Bazil Kavishe, John Changalucha, Aura Andreasen, Philippe Mayaud, Balthazar Gumodoka, Saidi Kapiga, Richard Hayes, Deborah Watson-Jones

10. Influenza vaccination and risk of hospitalization among adults with laboratory confirmed influenza illness Original Research Article

Available online 26 November 2013 Huong Q. McLean, Jennifer K. Meece, Edward A. Belongia

11. Estimation of the potential overall impact of human papillomavirus vaccination on cervical cancer cases and deaths Original Research Article

Available online 26 November 2013 Georges Van Kriekinge, Xavier Castellsagué, David Cibula, Nadia Demarteau

12. Disease-related adverse events following non-live vaccines: Investigation of a newly described reporting bias through the analysis of the WHO Global ICSR Database, VigiBase Original Research Article

Available online 26 November 2013 Giuseppe Roberto, Giovanna Zanoni

13. System factors to explain 2009 pandemic H1N1 state vaccination rates for children and high-risk adults in US emergency response to pandemic Original Research Article

Available online 25 November 2013 Carlo Davila-Payan, Julie Swann, Pascale M. Wortley

14. Epithelial stem cells as mucosal antigen-delivering cells: A novel AIDS vaccine approach Original Research Article

Available online 25 November 2013

Robert White, Nicole Chenciner, Gregory Bonello, Mary Salas, Philippe Blancou, Marie-Claire Gauduin

15. A global perspective of vaccination of healthcare personnel against measles: Systematic review Original Research Article

Available online 24 November 2013 Amy Parker Fiebelkorn, Jane F. Seward, Walter Orenstein

16. A reduction in chronic hepatitis B virus infection prevalence among children in Vietnam demonstrates the importance of vaccination Review Article

Available online 24 November 2013 Tran Hien Nguyen, Vu. Minh Huong, Cuong Nguyen, Lien Huong Nguyen, Kohei Toda, Tuyet Nga Nguyen, Sang Dao, Kathleen A. Wannemuehler, Karen A. Hennessey

Tabla de Contenidos. Volume 31, Issue 52, Pages 6161 – 6266 (16 December 2013).

1. Editorial Board/Aims and Scope

Pages CO2

Meeting reports

2. Third European Influenza Summit: Organized by the European Scientific Working group on Influenza (ESWI)

Pages 6161-6167 Janet McElhaney, Ab. Osterhaus

3. Haemophilus influenzae type b (Hib) Vaccination WHO position paper: July 2013-Recommendations

Pages 6168-6169 WHO

WHO paper

4. Rotavirus vaccines WHO position paper: January 2013 – Recommendations

Pages 6170-6171

Review

5. Ethical analyses of institutional measures to increase health care worker influenza vaccination rates Review Article

Pages 6172-6176 Richard K. Zimmerman

Regular papers

6. Serum antibody response to influenza virus vaccination during chemotherapy treatment in adult patients with solid tumours Original Research Article

Pages 6177-6184 M.L. Wumkes, A.M.T. van der Velden, M. Los, M.B.L. Leys, A. Beeker, M.R. Nijziel, A.W.G. van der Velden, M. Westerman, A. Meerveld-Eggink, G.F. Rimmelzwaan, G.T. Rijkers, D.H. Biesma

7. Increased efficacy of a trivalent nicotine vaccine compared to a dose- matched monovalent vaccine when formulated with alum Original Research Article

Pages 6185-6193 Sabina H.L. de Villiers, Katherine E. Cornish, Andrew J. Troska, Marco Pravetoni, Paul R. Pentel

8. Phase I/II trial of a replication-deficient trivalent influenza virus vaccine lacking NS1 Original Research Article

Pages 6194-6200 Christina Mössler, Franz Groiss, Michael Wolzt, Markus Wolschek, Joachim Seipelt, Thomas Muster

9. How many published cases of serious adverse events after yellow fever vaccination meet Brighton Collaboration diagnostic criteria? Original Research Article

Pages 6201-6209 Roger E. Thomas, Wendy Spragins, Diane L. Lorenzetti

10. Kinetics of influenza A virus nucleoprotein antibody (IgM, IgA, and IgG) in serum and oral fluid specimens from pigs infected under experimental conditions Original Research Article

Pages 6210-6215 Y. Panyasing, C.K. Goodell, L. Giménez-Lirola, A. Kittawornrat, C. Wang, K.J. Schwartz, J.J. Zimmerman

11. Comparison of the immune responses induced by soluble and particulate Plasmodium vivax circumsporozoite vaccine candidates formulated in AS01

in rhesus macaques Original Research Article

Pages 6216-6224 Yannick Vanloubbeeck, Sathit Pichyangkul, Babak Bayat, Kosol Yongvanitchit, Jason W. Bennett, Jetsumon Sattabongkot, Kurt Schaecher, Christian F. Ockenhouse, Joe Cohen, Anjali Yadava, the P. vivax vaccine study group

12. DNA immunization with eukaryotic initiation factor-2α of Toxoplasma gondii induces protective immunity against acute and chronic toxoplasmosis in mice Original Research Article

Pages 6225-6231 Jia Chen, Si-Yang Huang, Dong-Hui Zhou, Zhong-Yuan Li, Eskild Petersen, Hui-Qun Song, Xing-Quan Zhu

13. Prompt effect of replacing the 7-valent pneumococcal conjugate vaccine with the 13-valent vaccine on the epidemiology of invasive pneumococcal disease in Norway Original Research Article

Pages 6232-6238 Anneke Steens, Marianne A. Riise Bergsaker, Ingeborg S. Aaberge, Karin Rønning, Didrik F. Vestrheim

14. A replication-incompetent influenza virus bearing the HN glycoprotein of human parainfluenza virus as a bivalent vaccine Original Research Article

Pages 6239-6246 Hirofumi Kobayashi, Kiyoko Iwatsuki-Horimoto, Maki Kiso, Ryuta Uraki, Yurie Ichiko, Toru Takimoto, Yoshihiro Kawaoka

15. Binding and cleavage (BINACLE) assay for the functional in vitro detection of tetanus toxin: Applicability as alternative method for the safety testing of tetanus toxoids during vaccine production Original Research Article

Pages 6247-6253 Heike A. Behrensdorf-Nicol, Ursula Bonifas, Kay-Martin Hanschmann, Beate Krämer, Karin Weißer

16. RSV vaccine in development: Assessing the potential cost-effectiveness in the Dutch elderly population Original Research Article

Pages 6254-6260 M.J. Meijboom, K.B. Pouwels, W. Luytjes, M.J. Postma, E. Hak

17. Functionality of the pneumococcal antibody response in down syndrome subjects Original Research Article

Pages 6261-6265 M.A.A. Kusters, N.C.C. Manders, B.A.W. de Jong, R.W.N.M. van Hout, G.T. Rijkers, E. de Vries

Erratum

18. Erratum to: “Evidence Regarding Human Papillomavirus Testing in Secondary Prevention of Cervical Cancer” [Vaccine 30S5 (2012) F88–F99]

Pages 6266 Marc Arbyn, Guglielmo Ronco, Ahti Anttila, Chris J.L.M. Meijer, Mario Poljak, Gina Ogilvie, George Koliopoulos, Pontus Naucler, Rengaswamy Sankaranarayanan, Julian Peto 